PTC Therapeutics (NASDAQ:PTCT) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
PTC Therapeutics missed estimated earnings by 23.78%, reporting an EPS of $-2.03 versus an estimate of $-1.64.
Revenue was up $46.36 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.49 which was followed by a 4.09% increase in the share price the next day.
Here's a look at PTC Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1.40 | -1.82 | -1.51 | -0.94 |
| EPS Actual | -1.89 | -1.68 | -1.83 | -1.08 |
| Revenue Estimate | 126.44M | 110.50M | 98.80M | 111.36M |
| Revenue Actual | 138.74M | 116.68M | 117.94M | 118.86M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
.jpg?w=600)
